Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Clinical trial NCT07507760 · RECRUITING

Trial details

NCT number: NCT07507760
Sponsor: PETHEMA Foundation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia With Gene Mutations

Start date: 2026-06-12
Primary completion: 2029-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.